OPTPRESS or OPTPRESSIN? Authors' reply

Affiliations

¹ Department of Acute Critical Care Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan. akira.endo.0112@gmail.com.
² Department of Acute Critical Care and Disaster Medicine, Institute of Science Tokyo, Bunkyo, Tokyo, Japan. akira.endo.0112@gmail.com.
³ Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
⁴ Department of Emergency and Disaster Medicine, The Jikei University School of Medicine, Minato-Ku, Tokyo, Japan.
⁵ Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Sumiyoshi, Osaka, Japan.

Akira Endo et al. Intensive Care Med. 2025 Aug.

. 2025 Aug;51(8):1563-1564.

doi: 10.1007/s00134-025-08011-y. Epub 2025 Jun 30.

¹ Department of Acute Critical Care Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan. akira.endo.0112@gmail.com.
² Department of Acute Critical Care and Disaster Medicine, Institute of Science Tokyo, Bunkyo, Tokyo, Japan. akira.endo.0112@gmail.com.
³ Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
⁴ Department of Emergency and Disaster Medicine, The Jikei University School of Medicine, Minato-Ku, Tokyo, Japan.
⁵ Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Sumiyoshi, Osaka, Japan.

No abstract available

Conflict of interest statement

Declarations. Conflicts of interest: The authors declare no conflict of interest. Ethics statement: Not applicable.

1. Shi R, Wu J, Teboul JL (2025) OPTPRESS or OPTPRESSIN?. Intensive Care Med. https://doi.org/10.1007/s00134-025-08000-1 - DOI
1. Endo A, Yamakawa K, Tagami T et al (2025) Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial. Intensive Care Med 51:883–892. https://doi.org/10.1007/s00134-025-07910-4 - DOI
1. Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA 316:509–518. https://doi.org/10.1001/jama.2016.10485 - DOI
1. Russell JA (2019) Vasopressor therapy in critically ill patients with shock. Intensive Care Med 45:1503–1517. https://doi.org/10.1007/s00134-019-05801-z - DOI
1. Kalimouttou A, Kennedy JN, Feng J et al (2025) Optimal vasopressin initiation in septic shock: the OVISS reinforcement learning study. JAMA 333:1688–1698. https://doi.org/10.1001/jama.2025.3046 - DOI